Related Experiment Videos
Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis
1Department of Medicine, University of California, Los Angeles 90095-1670, USA. rasingh@med1.medsch.ucla.edu
Immunological Reviews
|October 31, 1998
Summary
Autoimmune diseases evolve, with immune responses diversifying over time. Targeting specific peptide determinants can delay disease onset and offers potential therapeutic strategies for autoimmune conditions.
Area of Science:
- Immunology
- Autoimmunity Research
Background:
- Autoimmune diseases were previously thought to stem from a single autoantigen.
- Emerging evidence suggests autoimmunity is a dynamic, evolving process.
Purpose of the Study:
- To investigate the concept of determinant spreading in autoimmune responses.
- To explore the role of reciprocal T-B cell stimulation in expanding autoimmune reactions.
- To assess the therapeutic potential of targeting autoantigenic determinants.
Main Methods:
- Described reciprocal T-B determinant spreading mechanism.
- Utilized tolerance induction to T-cell determinant peptides from an anti-DNA antibody VH region.
- Studied the NZB/NZW F1 mouse model of systemic lupus erythematosus.
Main Results:
- Demonstrated reciprocal T-B cell stimulation leads to expansion of T and B cell populations.
- Tolerance induction to specific peptides delayed IgG anti-dsDNA antibodies and lupus nephritis onset.
- Highlighted the continuous evolution and diversification of autoimmune responses.
Conclusions:
- Autoimmunity is an evolving process involving determinant spreading.
- Targeting specific peptide determinants is a promising therapeutic avenue.
- Understanding diversification patterns is crucial for developing effective peptide-targeted therapies.